RPID

Rapid Micro Biosystems Inc. Class A Common Stock (RPID)

Stock · NASDAQ · Industrials

$0.7608as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

RPID Presents at Small-Cap Virtual Conference. Rapid Micro Biosystems presented at a small‑cap virtual conference, sharing updates on its product pipeline and business strategy. The event offered investors a chance to hear directly from management about recent progress and future plans. The presentation follows the company’s recent trading activity, with an RSI of 31.3 and support near $1.66.

Active signals

Resistance level
$1.95
Industry
Biotechnology: Laboratory Analytical Instruments

What RPID's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike50-4.2%38%
Bollinger Band Breakdown27+0.4%52%
Bollinger Band Breakout20-1.4%50%
200-Day Moving Average TouchActive now13-4.9%31%
Any 20-session window (baseline)-3.5%42%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information manag…

Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Employees
171

Fundamentals

1-day range
$0.76$0.838
Market cap
$96.03M
P/E (trailing)
—
P/E (forward)
-1.07
EPS (trailing)
$-1.11
Dividend yield
—
Beta
1.47
Avg. volume
253.6K
52-week range
$0.8087$4.94
Next earnings: November 6, 2026 · EPS estimate $-0.20confirmed

How Rapid Micro Biosystems Inc. Class A Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$33.59MSG&A$34.84M (104%)Cost of Revenue$32.54M (97%)R&D$13.60M (41%)Tax$40.0K (0%)RPID

Source: 10-K filed Mar 12, 2026 · via SEC EDGAR / Finnhub

Gross Profit$1.05M(3%)
Operating Income-$47.39M(-141%)

Forecasts

4 analyst ratings

Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$8
+951.5%
Median
$6
+688.6%
Low
$3
+294.3%

Rapid Micro Biosystems Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • RPID
    Rapid Micro Biosystems Inc. Class A Common Stock
    $0.764
    ▼ 9.59%
    Market cap $96.03MP/E —
    $0.8087$4.94
  • NAUT
    Nautilus Biotechnology Inc. Common Stock
    $2.06
    ▼ 4.63%
    Market cap $112.76MP/E —
    $0.8399$4.31
  • SEER
    Seer Inc. Class A Common Stock
    $2.03
    ▼ 0.49%
    Market cap $120.41MP/E —
    $1.55$2.41
  • CIRC
    Circle8 Group Inc. Common Stock
    $0.302
    ▼ 5.33%
    Market cap $70.73MP/E —
    $0.3132$0.98
  • PRPO
    Precipio Inc. Common Stock
    $21.38
    ▼ 5.17%
    Market cap $41.93MP/E —
    $16.4$33.63
  • HBIO
    Harvard Bioscience Inc. Common Stock
    $8.09
    ▼ 2.65%
    Market cap $27.92MP/E —
    $3.75$9.4
  • ASTC
    Astrotech Corporation (DE) Common Stock
    $4.93
    ▼ 5.19%
    Market cap $18.10MP/E —
    $1.92$68.85

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
262.1K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
15.44M
Total value held
$35.04M
Institutional holders
42
Top holders this quarter
  • Unknown8.43M
  • Unknown1.85M
  • Unknown982.5K
  • Unknown883.9K
  • Unknown552.4K
  • Unknown432.5K
  • Unknown284.8K
  • Unknown283.3K
  • Unknown247.2K
  • Unknown212.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.